Sarilumab, Regeneron and Sanofi’s RA Drug, Flops in Severe COVID-19
Rheumatoid arthritis drug sarilumab was not an effective treatment for severely ill COVID-19 patients, according to the results of a phase 3 trial.
Related Articles
LGBTQ Dating App Grindr Under Fire for Selling Users’ Private Information to Advertisers | Docwire News
The LGBTQ dating app Grindr allegedly sold the private information of its users, including HIV status, to advertisers.
Dostarlimab, Chemotherapy Combo Is Cost Effective, Improves QOL for Endometrial Cancer Patients | Docwire News
The addition of dostarlimab to platinum chemotherapy is cost effective and significantly improves QOL in patients with endometrial cancer, according to a recent study.
Good Heart Health May Slow Cognitive Decline in Middle-Aged Black Women | Docwire News
Good heart health is linked to less cognitive decline among middle-aged Black women.
AI and Drug Development With Adam Petrich | Docwire News
Dr. Chadi Nabhan delves into the realm of AI and its impact on drug development with Dr. Petrich, chief medical officer of QuantHealth.
Breaking Down the Science of Aldosterone and Its Impact on Blood Pressure | Docwire News
Dr. Townsend details the science behind aldosterone, the hormone that regulates sodium and helps regulate blood pressure.
Dr. Raymond Townsend on Improving Adherence to Blood Pressure-Lowering Medications | Docwire News
Dr. Townsend discusses hypertension and how not adhering to medications is the biggest issue for patients.
NFL PLAY 60 Encourages Kids to Maintain a Healthy Lifestyle | Docwire News
The AHA and NFL collaborated on a fitness initiative that challenges kids to stay physically active in order to support their physical and mental health.
Investigating Sex Differences in Heritability of Autism Spectrum Disorder | Docwire News
There is variation in the heritability of ASD between men and women.
Dr. Timothy Yap on an Effective Therapy for HER2-Negative Breast Cancer | Docwire News
Dr. Timothy Yap discusses the PETRA trial, which showed the efficacy of saruparib in treating HER2-negative breast cancer.
Exploring the Link Between Lack of Neighborhood Opportunity and Breast Cancer Mortality | Docwire News
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.